← Leaderboards
Matthew Nojoomi
Ictero Medical, Inc.
$1,690,378
Attributed
$1,690,378
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2020–22$2M$1.5M$1M$500K$0
'20
'21
'22
Funding mix
By agency
NSF$1,690,378 · 2
By mechanism
—$1,690,378 · 2
Top collaborators
No co-investigators on record.
Grant awards (2)
SBIR Phase II: High Surface Area (HSA) Intraluminal Cryoablation for the Treatment of High-Risk Patients with Gallstone Disease$1,466,649
· FY2022 · TIP · contact PI
SBIR Phase I: High Surface Area (HSA) Intraluminal Cryoablation for the Treatment of High-risk Patients with Gallstone Disease$223,729
· FY2020 · TIP · contact PI